Bristol-Myers Squibb
BMY
BMY
2,381 hedge funds and large institutions have $91B invested in Bristol-Myers Squibb in 2023 Q3 according to their latest regulatory filings, with 118 funds opening new positions, 777 increasing their positions, 1,186 reducing their positions, and 181 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $102B → $91B (-$11.1B)
34% less repeat investments, than reductions
Existing positions increased: 777 | Existing positions reduced: 1,186
35% less first-time investments, than exits
New positions opened: 118 | Existing positions closed: 181
Holders
2,381
Holding in Top 10
42
Calls
$2.31B
Puts
$1.8B
Top Buyers
| 1 | +$291M | |
| 2 | +$193M | |
| 3 | +$148M | |
| 4 |
IFP
Independent Franchise Partners
London,
United Kingdom
|
+$135M |
| 5 |
Morgan Stanley
New York
|
+$101M |
Top Sellers
| 1 | -$403M | |
| 2 | -$245M | |
| 3 | -$228M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$224M |
| 5 |
State Street
Boston,
Massachusetts
|
-$190M |